Case report reveals persistent bleeding and abnormal coagulation tests despite bypassing agents in a postsurgery patient, highlighting therapeutic challenges of factor V inhibitors.
This case report highlights the challenges in controlling bleeding and correcting coagulation tests through the use of bypassing agents in patients with FV inhibitors.
No takes yet. Share an insight, caveat, or question.
Bruna et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: